Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-07
2011-06-07
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S009000
Reexamination Certificate
active
07956085
ABSTRACT:
This invention relates to Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof.
REFERENCES:
patent: 5994391 (1999-11-01), Lee et al.
patent: 2004/0087648 (2004-05-01), Frick et al.
patent: WO 03/018024 (2003-03-01), None
patent: WO 03/040127 (2003-05-01), None
patent: WO 2004/076430 (2004-09-01), None
patent: WO 2007/009655 (2007-01-01), None
Saito, S., et al., Synthesis of Glycymhetic Acid Diglycosides and Their Cytoprotective Activities Against CCI4-Induced Hepatic Injury in Vitro, Eur. J. Med. Chem.. (1996), vol. 31, pp. 557-574.
Pozsgay, V., et al., Synthesis of Kojidextrins and Their Protein Conjugates. Incidence of Steric Mismatch in Oligosaccharide Synthesis, J. Org. Chem., (1997), vol. 62, pp. 2832-2846.
Frick Wendelin
Glombik Heiner
Heuer Hubert
Kramer Werner
Schaefer Hans-Ludwig
Sanofi-Aventis Deutschland GmbH
Scully , Scott, Murphy & Presser, P.C.
Solola Taofiq A
LandOfFree
1,4-benzothiepine 1,1-dioxide derivatives substituted by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-benzothiepine 1,1-dioxide derivatives substituted by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-benzothiepine 1,1-dioxide derivatives substituted by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2718875